Non Invasive Intracranial Pressure Monitoring Device Market Summary
According to MRFR analysis, the Non-Invasive Intracranial Pressure Monitoring Device Market size was valued at USD 2.473 Billion in 2024. The market is projected to grow from USD 2.636 Billion in 2025 to USD 4.99 Billion by 2035, registering a CAGR of 6.59% during the forecast period 2025–2035. North America led the Non-Invasive Intracranial Pressure Monitoring Device Market with over 44% share, generating around USD 1.1 billion in revenue.
The Non-Invasive Intracranial Pressure Monitoring Device Market is growing due to rising neurological disorders, increasing demand for minimally invasive diagnostics, and technological advancements in monitoring systems. Key trends include AI-enabled monitoring, advanced sensor technologies, and adoption of patient-centric solutions that enable real-time brain pressure monitoring while improving safety and clinical decision-making.
The Centers for Disease Control and Prevention reports that traumatic brain injury contributes to about 30% of all injury-related deaths in the United States, highlighting the importance of effective intracranial pressure monitoring solutions.
Key Market Trends & Highlights
The Non-Invasive Intracranial Pressure Monitoring Device Market is experiencing robust growth driven by technological advancements and increasing demand for patient-centric solutions.
- Technological advancements are propelling the development of more accurate and efficient non-invasive monitoring devices.
- North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for these devices.
- The ultrasound segment dominates the market, whereas the optical segment is witnessing rapid growth due to its innovative applications.
- Key market drivers include the rising incidence of neurological disorders and a growing focus on minimally invasive procedures.
Market Size & Forecast
| 2024 Market Size | 2.473 (USD Billion) |
| 2035 Market Size | 4.99 (USD Billion) |
| CAGR (2025 - 2035) | 6.59% |
Major Players
Natus Medical Incorporated (US), Medtronic plc (IE), Raumedic AG (DE), NeuroWave Systems, Inc. (US), HeadSense Medical Ltd. (IL), OptiNose, Inc. (US), Codman Neuro (US), Cerebrotech Medical Systems, Inc. (US)